State Council of China
44 data points extracted from 7 publications by this organisation.
Data points
44
Documents
7
Indicators
36
Regions
1
Publisher type
Government
Bibliography
Documents used
Every publication we have taken a number from, with the date we read it and the link status at that time.
| Document | Type | Published | Retrieved | Link | Data points |
|---|---|---|---|---|---|
| Measures facilitate approval of 48 first-in-class innovative drugs Licence: See source | Press release | — | 17 Sep 2026 | Reachable | 12 |
| 2024年版国家医保药品目录出炉，新增91种药品——让参保人用上更多新药好药_政策解读_中国政府网 Licence: See source | Press release | — | 17 Sep 2026 | Reachable | 10 |
| China scales up support for clinical trials, accelerating drug development Licence: See source | Press release | — | 17 Sep 2026 | Reachable | 3 |
| Value of China's innovative drug out-licensing deals hit new high in H1 Licence: See source | Press release | — | 17 Sep 2026 | Reachable | 7 |
| China updates national medical insurance catalog, adds 114 new drugs Licence: See source | Press release | — | 17 Sep 2026 | Reachable | 4 |
| 全面深化监管改革 缩短临床试验审评审批时限——加快创新药和医疗器械上市_政策解读_中国政府网 Licence: See source | Press release | — | 17 Sep 2026 | Reachable | 2 |
| China to expand health insurance coverage for innovative drugs Licence: See source | Press release | — | 17 Sep 2026 | Reachable | 6 |
Every figure
Data points
Every figure taken from this organisation, grouped by indicator.
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. Credit State Council of China as the original publisher; each record page carries its own citation.
State Council of China. Retrieved from StatOrigin: https://statorigin.org/sources/state-council-of-china
Keep exploring
Related
Industries using this source
Last verified 17 September 2026. Link status is rechecked weekly.